US 12258367
Glucoside derivative that acts as SGLT1 inhibitor and application thereof
granted A61PA61P3/04A61P3/10
Quick answer
US patent 12258367 (Glucoside derivative that acts as SGLT1 inhibitor and application thereof) held by Medshine Discovery Inc. expires Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Medshine Discovery Inc.
- Grant date
- Tue Mar 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61P, A61P3/04, A61P3/10